Ekman Lars

Related Filers (8)

Ownership (80)

4
Friday, 5/19/2023
PROTHENA CORP PUBLIC LTD CO: Statement of changes in beneficial ownership of securities
4
Thursday, 1/5/2023
PROTHENA CORP PUBLIC LTD CO: Statement of changes in beneficial ownership of securities
4
Friday, 12/2/2022
PROTHENA CORP PUBLIC LTD CO: Statement of changes in beneficial ownership of securities
4
Thursday, 11/3/2022
PROTHENA CORP PUBLIC LTD CO: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/5/2022
PROTHENA CORP PUBLIC LTD CO: Statement of changes in beneficial ownership of securities
4
Friday, 9/30/2022
PROTHENA CORP PUBLIC LTD CO: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/29/2022
AMARIN CORP PLC\UK: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/28/2022
Ultragenyx Pharmaceutical Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/27/2022
PROTHENA CORP PUBLIC LTD CO: Statement of changes in beneficial ownership of securities
4
Monday, 6/28/2021
Ultragenyx Pharmaceutical Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/16/2021
AMARIN CORP PLC\UK: Statement of changes in beneficial ownership of securities
4
Friday, 5/21/2021
PROTHENA CORP PUBLIC LTD CO: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/17/2021
PROTHENA CORP PUBLIC LTD CO: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/15/2020
AMARIN CORP PLC\UK: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/30/2020
Ultragenyx Pharmaceutical Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/22/2020
Prothena Corp plc: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/17/2019
Spark Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/13/2019
AMARIN CORP PLC\UK: Statement of changes in beneficial ownership of securities
4
Thursday, 11/7/2019
AMARIN CORP PLC\UK: Statement of changes in beneficial ownership of securities
4
Thursday, 9/5/2019
AMARIN CORP PLC\UK: Statement of changes in beneficial ownership of securities
4
Friday, 6/28/2019
SOPHIRIS BIO INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/13/2019
Ultragenyx Pharmaceutical Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/3/2019
Spark Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/24/2019
Prothena Corp plc: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/21/2019
AMARIN CORP PLC\UK: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/6/2019
AMARIN CORP PLC\UK: Statement of changes in beneficial ownership of securities
4
Friday, 1/11/2019
AMARIN CORP PLC\UK: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/2/2018
AMARIN CORP PLC\UK: Statement of changes in beneficial ownership of securities
4
Thursday, 6/28/2018
SOPHIRIS BIO INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/20/2018
Ultragenyx Pharmaceutical Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/31/2018
Spark Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/18/2018
Prothena Corp plc: Statement of changes in beneficial ownership of securities
4
Thursday, 6/22/2017
Ultragenyx Pharmaceutical Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/2/2017
Spark Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/1/2017
SOPHIRIS BIO INC.: Statement of changes in beneficial ownership of securities
4
Friday, 5/19/2017
Prothena Corp plc: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/17/2017
AMARIN CORP PLC\UK: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/13/2016
AMARIN CORP PLC\UK: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/14/2016
Ultragenyx Pharmaceutical Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/3/2016
Spark Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/31/2016
SOPHIRIS BIO INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/24/2016
Prothena Corp plc: Statement of changes in beneficial ownership of securities
3
Monday, 3/21/2016
Ultragenyx Pharmaceutical Inc.: Initial statement of beneficial ownership of securities
4
Monday, 3/21/2016
Ultragenyx Pharmaceutical Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/25/2015
Prothena Corp plc: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/8/2015
AMARIN CORP PLC\UK: Statement of changes in beneficial ownership of securities
4
Thursday, 5/28/2015
SOPHIRIS BIO INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/26/2015
Prothena Corp plc: Statement of changes in beneficial ownership of securities
3
Thursday, 1/29/2015
Spark Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 1/23/2015
SOPHIRIS BIO INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/1/2014
INTERMUNE INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/18/2014
SOPHIRIS BIO INC.: Statement of changes in beneficial ownership of securities
4
Friday, 6/13/2014
Ocera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/2/2014
INTERMUNE INC: Statement of changes in beneficial ownership of securities
4
Thursday, 3/13/2014
AMARIN CORP PLC\UK: Statement of changes in beneficial ownership of securities
4
Monday, 12/23/2013
Ocera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/20/2013
AMARIN CORP PLC\UK: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/29/2013
SOPHIRIS BIO INC.: Statement of changes in beneficial ownership of securities
3
Friday, 8/16/2013
SOPHIRIS BIO INC.: Initial statement of beneficial ownership of securities
3
Wednesday, 7/17/2013
Ocera Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 7/17/2013
Ocera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/11/2013
AMARIN CORP PLC\UK: Statement of changes in beneficial ownership of securities
4
Monday, 6/3/2013
INTERMUNE INC: Statement of changes in beneficial ownership of securities
4
Thursday, 1/31/2013
Prothena Corp plc: Statement of changes in beneficial ownership of securities
3
Friday, 12/21/2012
Prothena Corp plc: Initial statement of beneficial ownership of securities
4
Thursday, 7/12/2012
AMARIN CORP PLC\UK: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/6/2012
INTERMUNE INC: Statement of changes in beneficial ownership of securities
4
Thursday, 5/12/2011
INTERMUNE INC: Statement of changes in beneficial ownership of securities
3
Thursday, 12/30/2010
AMARIN CORP PLC\UK: Initial statement of beneficial ownership of securities
4
Monday, 9/27/2010
INTERMUNE INC: Statement of changes in beneficial ownership of securities
4
Monday, 5/10/2010
INTERMUNE INC: Statement of changes in beneficial ownership of securities
4
Monday, 5/3/2010
ARYx Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/24/2009
INTERMUNE INC: Statement of changes in beneficial ownership of securities
4
Friday, 5/1/2009
ARYx Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/15/2008
INTERMUNE INC: Statement of changes in beneficial ownership of securities
4
Friday, 11/9/2007
ARYx Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 11/7/2007
ARYx Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 5/17/2007
INTERMUNE INC: Statement of changes in beneficial ownership of securities
3
Thursday, 9/21/2006
INTERMUNE INC: Initial statement of beneficial ownership of securities
4
Wednesday, 9/20/2006
INTERMUNE INC: Statement of changes in beneficial ownership of securities
Show More